Multi-gene panel testing revealed no mutations in the mismatch repair, BRCA1/2, or PTEN genes but a deleterious frameshift mutation in RAD50, a moderate penetrance breast cancer gene. The gene discussed is RAD50; the disease is breast carcinoma.